BeiGene to price US IPO early
Chinese drug maker BeiGene has decided to price its US listing on Tuesday evening, a day earlier than planned, according to sources close to the deal.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: